Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 49 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
DeSalvo KB, Olson R, Casavale KO. Dietary guidelines for Americans. JAMA 2016;315:457-8. [Ref.ID 100020]
2. Cita con resumen
Mozaffarian D, Ludwig DS. The 2015 US dietary guidelines: lifting the ban on total dietary fat. JAMA 2015;313:2421-2. [Ref.ID 99229]
4.Enlace a cita original Cita con resumen
Li S, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Rexrode KM, Mukamal KJ, Rimm EB. Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study. BMJ 2014;348:g2659. [Ref.ID 97537]
6. Cita con resumen
Karppi J, Laukkanen JA, Sivenius J, Ronkainen K, Kurl S. Serum lycopene decreases the risk of stroke in men. A population-based follow-up study. Neurology 2012;79:1540-7. [Ref.ID 93141]
7.Tiene citas relacionadas Cita con resumen
Aune D, Chan DSM, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011;343:1082. [Ref.ID 91853]
8.Tiene citas relacionadas
Anónimo. Fibre and prevention of chronic diseases. BMJ 2011;343:1075. [Ref.ID 91852]
9. Cita con resumen
Sayburn A. Eating "5 a day" provides tittle protections against cancer. BMJ 2010;340:830. [Ref.ID 88337]
10. Cita con resumen
Nyirenda MJ, Tang JI, Padfield PL, Seckl JR. Hyperkalaemia. BMJ 2009;339:1019-24. [Ref.ID 86996]
11. Cita con resumen
Djoussé L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009;302:394-400. [Ref.ID 86293]
12.Tiene citas relacionadas
McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S, for the INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-33. [Ref.ID 83625]
13.Tiene citas relacionadas
Lind L. Apolipoprotein B/A1 and risk of cardiovascular disease. Lancet 2008;372:185-6. [Ref.ID 83619]
14. Cita con resumen
Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O, on behalf of EUROACTION Study Group. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008;371:1999-2012. [Ref.ID 83251]
15.
Tonks A. A spoonful of antigen. BMJ 2007;335:180-2. [Ref.ID 80700]
16. Cita con resumen
López AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57. [Ref.ID 77046]
17. Cita con resumen
Danaei G, Hoom SV, López AD, Murray CJL, Ezzati M, and the Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784-93. [Ref.ID 75487]
18.Tiene citas relacionadas Cita con resumen
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. [Ref.ID 71323]
20.Tiene citas relacionadas Cita con resumen
Concato J, Horwitz RI. Observational versus randomised trial evidence. Authors' reply. Lancet 2004;364:757. [Ref.ID 71214]
Seleccionar todas
 
 1 a 20 de 49 siguiente >>